hydralazine has been researched along with ADPKD in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Excerpt | Relevance | Reference |
---|---|---|
" However, although chronic enalapril and hydralazine protect against the loss of renal function, only enalapril limits renal growth and proteinuria, and neither significantly limits tubulointerstitial fibrosis." | 3.70 | Hypertension and renal injury in experimental polycystic kidney disease. ( Al-Nimri, MA; Anderson, S; Chapman, JG; Kelly, FJ; Kennefick, TM; Oyama, TT; Thompson, MM, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kennefick, TM | 1 |
Al-Nimri, MA | 1 |
Oyama, TT | 1 |
Thompson, MM | 1 |
Kelly, FJ | 1 |
Chapman, JG | 1 |
Anderson, S | 1 |
1 other study available for hydralazine and ADPKD
Article | Year |
---|---|
Hypertension and renal injury in experimental polycystic kidney disease.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Enalapril; Fibrosis; Hydralazine; Hypertension, Re | 1999 |